Hannah Howie was a year away from getting married when a revelation from the past turned her life upside down.
AstraZeneca could become the first company to bring an oral selective oestrogen receptor degrader (SERD) drug to market as a first-line ... breast cancer whose tumours express ESR1 gene mutations ...